Home » Posts tagged 'pharmaceuticals'

Tag Archives: pharmaceuticals

Prescription Drug Coupons: A One-Size-Fits-All Policy Approach Doesn’t Fit The Evidence

Critics of prescription drug copayment coupons contend that they force insurers to cover more expensive brand drugs and cause overall costs to rise. The counterpoint is notes that with rising drug copayments, coupons reduce patients’ out-of-pocket costs and provide access to needed therapies. The truth is more complex.  (more…)

Pharmaceutical Industry Profits And Research And Development

Paul Ginsburg and Richard Frank question the premise that more innovation is always a good thing.  (more…)

Election verdict: Pharma Needs a New Prescription

Dana Goldman and Darius Lakdawalla provide a policy prescription list for the pharmaceutical industry aimed at improving access for patients today without discouraging investments into tomorrow’s medical innovations.  (more…)

A New Line of Specialty Drugs: PCSK9 Inhibitors (Part 2)

This fall, a new line of specialty drugs will hit the market- PCSK9 inhibitors.  PCSK9 inhibitors are a new class of drugs used to lower LDL (bad) cholesterol levels through stifling a protein (PCSK9). The drug is injected once or twice a month and is (more…)

Follow CESR on Facebook

Follow Schaeffer on Facebook